Hematology & Blood Cancer
Advertisement
Josie Montegaard, NP, shares how nurses can help patients mitigate and manage negative CLL treatment side effects.
Researchers analyzed clinical outcomes because hematopoietic SCT is becoming more a more accessible and utilized treatment.
Research presented at the NCCN Annual Conference illuminated patient experiences with tyrosine kinase inhibitors.
Researchers assessed the cost effectiveness of ibrutinib, acalabrutinib, and zanubrutinib in multiple treatment settings.
Researchers investigated underlying drivers of HRQOL degradation in CLL, including muscle weakness and fatigue.
Amy Pierre, RN, BSN, ANP-BC, shares her insights on the importance of Multiple Myeloma Awareness Month.
Josie Montegaard, NP, discusses key guidelines, criteria, and the need for flexibility when initiating treatment for CLL.
Previous research showed a potential connection between obesity and moderate to severe GVHD post-allogeneic SCT.
Learn how ACCESS study data is informing patient-centered GVHD care and eliminating the donor access barrier for HSCT trials.
Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.
The clinically focused intervention invovled a symptom assessment questionnaire followed by symptom support.
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
Krystal Waldrup, BSN, RN, OCN, shares how the training improved nurse confidence and opened up capacity in the oncology unit.
Anna Barata, PhD, shares key insights from the CAR-T research that she presented during the 2025 Tandem Meetings.
Chelsea Honstain, NP, is vice chair of the APP Steering Committee and chair of the Education Subcommittee.
The Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR are taking place February 12-15.
The Lee Symptom Scale for skin sclerosis was informed by patient interviews and feedback.
The study highlights the need for improved patient education and provider communication on early symptoms of cGVHD.
Amy Pierre, RN, BSN, ANP-BC, explains why it's important for advanced practice nurses to be invovled in research.
Pierluigi Porcu, MD, discusses the phase II Tellomak trial and how nurses can help patients manage this rare disease.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.